| Higher-Dose Maintenance With ERZOFRI 351 mg in Adults With Schizophrenia | Paliperidone, Paliperidone palmitate | Phase 4 | Not yet recruiting | Alejandro Alva | 2026-11-10 |
| Sequential Treatment Approaches for Treatment-Resistant Schizophrenia | Aripiprazole, Clozapine | Phase 3 | Recruiting | Shanghai Mental Health Center | 2026-11-05 |
| Phase 3 Study of HS-10380 for Acute Schizophrenia in Chinese Adults | Aripiprazole | Phase 3 | Not yet recruiting | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2026-11-03 |
| Quality of Life, Safety and Compliance of Patients Using Monotherapy or Combinatorial Therapy With Quetiapine for Treatment of Schizophrenia or Bipolar Affective Disorder | Aripiprazole, Quetiapine | — | Recruiting | Bosnalijek D.D | 2026-10-05 |
| Lumateperone Added to Antidepressant Therapy in Adults With Major Depressive Disorder Experiencing Emotional Blunting | Lumateperone | Phase 4 | Not yet recruiting | Future Options Research, LLC | 2026-09-17 |
| Effects of Nitraria Retusa Infusion on Clozapine-induced Metabolic Side Effects | Clozapine | Not applicable | Recruiting | Faculty of Medicine, Sousse | 2026-09-14 |
| The BAARD Study : Evaluating a Computerized Approach to Treatment Selection in Older Adults With Treatment Resistant Depression. | Aripiprazole | Phase 2 | Not yet recruiting | Washington University School of Medicine | 2026-09-09 |
| Broadband Near Infrared Spectroscopy to Understand the Role of Brain Cytochrome C Oxidase in Bipolar Disorder | Lurasidone | Phase 4 | Not yet recruiting | Martin Lan | 2026-09-08 |
| Discontinuing Psychotropic Medication Before Psychotherapy for PTSD | Quetiapine | — | Not yet recruiting | Academic Centre for Dentistry in Amsterdam | 2026-09-03 |
| Caplyta Versus Placebo for Adults With Social Anxiety Disorder | Lumateperone | Phase 4 | Recruiting | Jason Careri | 2026-09-02 |
| Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101 | Lurasidone | Early phase 1 | Recruiting | Mclean Hospital | 2026-08-25 |
| Study of Lurasidone as Adjunctive Treatment in Patients With Major Depressive Disorder With Inadequate Response to Antidepressant Monotherapy | Lurasidone | Phase 3 | Not yet recruiting | Bukwang Pharmaceutical | 2026-08-24 |
| Study of rTMS in Maintenance in Treatment Resistant Depression | Quetiapine | Phase 3 | Not yet recruiting | All India Institute of Medical Sciences, Bhubaneswar | 2026-08-12 |
| A Study of Lumateperone Versus Placebo in Participants With Major Depressive Disorder | Lumateperone | Phase 3 | Not yet recruiting | Intra-Cellular Therapies, Inc. | 2026-08-05 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Brexpiprazole for Extended-Release Injection in Subjects With Schizophrenia | Brexpiprazole | Phase 2 / Phase 3 | Not yet recruiting | Bostal Drug Delivery Co., Ltd | 2026-08-03 |
| Routine Antiemetic Prophylaxis for Nonfasted Parturients Undergoing Cesarean Sections Under Spinal Anesthesia | Metoclopramide | Phase 4 | Recruiting | Sanliurfa Education and Research Hospital | 2026-07-31 |
| Lumateperone in the Treatment of Stuttering, Childhood Onset Fluency Disorder | Lumateperone | Phase 2 | Recruiting | CSTrials Inc. | 2026-07-29 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of Viaca (Sildenafil + Cabergoline) Compared With Sildenafil and Cabergoline | Cabergoline | Phase 1 | Not yet recruiting | Yanping Kong | 2026-07-28 |
| Vonoprazan Alone vs With Itopride for Functional Dyspepsia: The VIVA Trial | Itopride | Not applicable | Recruiting | Asian Institute of Gastroenterology, India | 2026-07-28 |
| Single-case Intervention Study for Visual Screening Assessment for Proof of Concept and Prediction of Clinical Response to Brexiprazole as Adjunctive Treatment in Adults With Major Depressive Disorder. | Brexpiprazole | Not applicable | Active, not recruiting | University of Sao Paulo | 2026-07-23 |
| A Study to Investigate Pharmacokinetics, Safety, and Tolerability of B2227 Extended-Release Injectable Suspension and Vraylar® in Participants With Schizophrenia | Cariprazine | Phase 2 / Phase 3 | Not yet recruiting | Bostal Drug Delivery Co., Ltd | 2026-07-23 |
| ZR001 Chemogenetics Gene Therapy Study in Patients With Parkinson's Disease | Clozapine | Phase 1 | Not yet recruiting | Qianfoshan Hospital | 2026-07-22 |
| Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE) | Aripiprazole | Phase 2 | Not yet recruiting | Christiana Franke | 2026-07-20 |
| Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in Schizophrenia | Brexpiprazole, Cariprazine | Phase 1 | Not yet recruiting | New York State Psychiatric Institute | 2026-07-20 |
| Evaluating Safety and Efficacy of VV119 in Acute Schizophrenia Adults | Aripiprazole | Phase 2 | Not yet recruiting | Vigonvita Life Sciences | 2026-07-15 |
| MicroRNAs as Biomarkers in First Episode Schizophrenia | Aripiprazole, Risperidone | Not applicable | Recruiting | Northwell Health | 2026-07-14 |
| The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression | Lumateperone | Phase 4 | Recruiting | Massachusetts General Hospital | 2026-07-13 |
| This Study Aims to Compare the Efficacy and Safety of Lumateperone and Cariprazine in Patients With Bipolar I Depression Using Montgomery-Åsberg Depression Rating Scale (MADRS) and Clinical Global Impression Bipolar Severity Scale (CGI-BP-S) and Recording Treatment Emergent Adverse Effects | Cariprazine, Lumateperone | Phase 4 | Not yet recruiting | Watim Medical & Dental College | 2026-06-30 |
| Risperidone vs Cariprazine in Acute Mania | Cariprazine, Risperidone | Phase 4 | Not yet recruiting | Pakistan Institute of Medical Sciences | 2026-06-24 |
| Efficacy and Mechanism of IPSRT for Bipolar II Disorder | Quetiapine | Phase 2 | Not yet recruiting | First Affiliated Hospital of Zhejiang University | 2026-06-17 |
| Time to First Rescue Antiemetic With Ondansetron Plus Metoclopramide Versus Dexamethasone Plus Metoclopramide for PONV Prophylaxis in Laparoscopic Cholecystectomy | Metoclopramide | Phase 4 | Recruiting | Faisalabad Medical University | 2026-06-10 |
| Intravenous Metoclopramide Versus Intravenous Acetaminophen for Acute Concussion Treatment | Metoclopramide | Phase 4 | Not yet recruiting | Montefiore Medical Center | 2026-06-08 |
| Lumateperone for Late-Life Depression | Lumateperone | Phase 3 | Recruiting | Eric Lenze | 2026-06-03 |
| Postoperative GI Dysfunction and Nutrition in Malnourished Cancer Surgery Patients | Metoclopramide | — | Not yet recruiting | Arma Ltd. | 2026-06-03 |
| A 20-Year Follow-up of First Episode Psychosis: Longitudinal Effects of Early Treatment Strategies and Relapse | Quetiapine | — | Recruiting | The University of Hong Kong | 2026-06-01 |
| Pridopidine Phase 3 Study in Huntington's Disease | Pridopidine | Phase 3 | Recruiting | Prilenia | 2026-05-27 |
| No Guts No Glory Probiotics | Clozapine, Quetiapine, Risperidone | Phase 2 / Phase 3 | Recruiting | University Medical Center Groningen | 2026-05-26 |
| Combination Osilodrostat and Cabergoline in Cushing's Disease | Cabergoline | Phase 4 | Enrolling by invitation | University of Basrah | 2026-05-22 |
| Dexamethasone Plus Metoclopramide Versus Paracetamol/NSAIDs for Primary Headache | Metoclopramide | Phase 4 | Not yet recruiting | Pak Emirates Military Hospital | 2026-05-22 |
| Effect of Digestive Enzymes as Add on Therapy on Patients With Functional Dyspepsia. | Domperidone | Phase 4 | Not yet recruiting | Rakibul Mostafa | 2026-05-11 |
| Evaluating the Impact of Ketogenic Therapy on Symptom Severity and Metabolic Side Effect Profile Among Individuals Living With Bipolar Disorder in A Rural Southern Catchment Area | Aripiprazole, Quetiapine, Risperidone | Not applicable | Not yet recruiting | University of Alabama at Birmingham | 2026-05-06 |
| Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes | Cabergoline | Not applicable | Enrolling by invitation | Enhanced Emirates Limited | 2026-05-06 |
| Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications | Risperidone | Phase 3 | Recruiting | Minerva Neurosciences | 2026-05-04 |
| Clinical Study of Chemogenetic Gene Therapy With AAV for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic Nucleus | Clozapine | Early phase 1 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-04-16 |
| Shortened LSD Intervention for Major Depressive Disorder | Risperidone | Phase 1 | Not yet recruiting | Johns Hopkins University | 2026-03-31 |
| Efficacy of Cabergoline in Inhibiting Lactation and Alleviating Breast Symptoms | Cabergoline | Phase 2 | Recruiting | Jefferson Drapkin | 2026-03-25 |
| A Bioequivalence Study of PP3M in Patients With Schizophrenia | Paliperidone, Paliperidone palmitate | Not applicable | Recruiting | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 2026-03-25 |
| Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects | Risperidone | Phase 1 | Recruiting | Medical University of Vienna | 2026-03-24 |
| Evaluate Pharmacokinetics, Safety, and Tolerability of AX251 LAI in Patients With Schizophrenia | Cariprazine | Phase 1 | Recruiting | Anxo Pharmaceutical Co., Ltd. | 2026-03-20 |
| Cerebellum-based Imaging Neural Markers for Antipsychotic Response | Risperidone | Phase 4 | Recruiting | Northwell Health | 2026-03-19 |
| Safety and Potency of a High Cabergoline Dosage in Microprolactinomas | Cabergoline | Phase 3 | Recruiting | University of Sao Paulo General Hospital | 2026-03-11 |
| Comparing Acotiamide and Itopride for the Management of Indigestion | Itopride | Phase 4 | Not yet recruiting | Aga Khan University | 2026-03-04 |
| Standardized Sleep Bundle for Cardiac Surgery Patients | Quetiapine | Not applicable | Recruiting | Horizon Health Network | 2026-02-11 |
| Carbergoline for Antipsychotic Induced Hyperprolactinemia. | Cabergoline | Phase 4 | Not yet recruiting | Zealand University Hospital | 2026-02-04 |
| Neurocircuitry Mechanisms and Efficacy of Lumateperone as Adjunctive Therapy for Major Depressive Disorder and History of Early Life Abuse | Lumateperone | Phase 4 | Not yet recruiting | University of Texas at Austin | 2026-01-27 |
| Granisetron Combined With Dexamethasone or Metoclopramide for PONV Prevention After Laparoscopic Cholecystectomy | Metoclopramide | Phase 4 | Not yet recruiting | Assiut University | 2026-01-22 |
| IV Injection of Metoclopramide With or Without Dexamethasone | Metoclopramide | Early phase 1 | Not yet recruiting | Ahmed Nassar Ibrahim Mohammed | 2026-01-15 |
| Stratification and Treatment in Early Psychosis Study -ASSIST | Clozapine | Phase 3 | Not yet recruiting | University of Oxford | 2026-01-08 |
| Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS | Pridopidine | Phase 3 | Recruiting | Prilenia | 2026-01-07 |
| RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE) | Cariprazine | Phase 4 | Recruiting | Mayo Clinic | 2025-12-05 |
| Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial | Trimipramine | Phase 2 | Recruiting | Centre Hospitalier Universitaire Vaudois | 2025-12-04 |
| Cabergoline & Letrozole Versus Letrozole in Ovulation Induction in PCOS | Cabergoline | Not applicable | Recruiting | Mst.Sumyara Khatun | 2025-12-01 |
| A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Robotic Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS Trial | Lurasidone | Phase 2 / Phase 3 | Recruiting | NeuroRx, Inc. | 2025-11-12 |
| Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting | Metoclopramide | Phase 3 | Recruiting | Affiliated Hospital of Qinghai University | 2025-10-06 |
| Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine | Cariprazine | Phase 1 / Phase 2 | Recruiting | Mapi Pharma Ltd. | 2025-09-22 |
| Acotiamide vs Itopride in Postprandial Distress Syndrome | Itopride | Phase 3 | Not yet recruiting | Getz Pharma | 2025-09-15 |
| Postprandial Distress Itopride Cohort Trial | Itopride | — | Not yet recruiting | Universitaire Ziekenhuizen KU Leuven | 2025-09-10 |
| Efficacy and Safety of Paliperidone in Schizophrenia - Bangladesh Study | Paliperidone | Phase 4 | Not yet recruiting | Sher-E-Bangla Medical College | 2025-09-04 |
| A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate Tablets | Cabergoline | Phase 3 | Recruiting | Changchun GeneScience Pharmaceutical Co., Ltd. | 2025-08-15 |
| MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use Disorder | Fluspirilene | Phase 2 / Phase 3 | Recruiting | VA Office of Research and Development | 2025-08-12 |
| Domperidone and the Risk of Serious Adverse Events | Domperidone | — | Active, not recruiting | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2025-08-01 |
| Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension | Iloperidone | Phase 2 | Recruiting | Vanda Pharmaceuticals | 2025-07-29 |
| A Clinical Study of the Safety and Efficacy of Chemogenetics Therapy in the Treatment of Parkinson's Disease | Clozapine | Early phase 1 | Not yet recruiting | Ruijin Hospital | 2025-07-25 |
| Non-opioid Anesthesia Based on Thoracic Paravertebral Block During Laparoscopic Sleeve Gastrectomy | Thiethylperazine | Not applicable | Not yet recruiting | IVO JURISIC | 2025-07-24 |
| Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics in Schizophrenia | Paliperidone, Paliperidone palmitate | Phase 4 | Not yet recruiting | Jiangsu Province Nanjing Brain Hospital | 2025-07-20 |
| Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR. | Clozapine, Paliperidone, Paliperidone palmitate, Asenapine | Phase 4 | Active, not recruiting | Dr. Stavroula Rakitzi | 2025-07-02 |
| Efficacy of Itopride Versus Metoclopramide in Hospitalized Medicine Patients With High Gastric Residual Volume | Itopride | Phase 4 | Not yet recruiting | Chulalongkorn University | 2025-06-22 |
| Randomized Withdrawal Study in Patients With Schizophrenia | Iloperidone | Phase 3 | Recruiting | Vanda Pharmaceuticals | 2025-05-08 |
| Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines | Prochlorperazine | Phase 3 | Recruiting | Wake Forest University Health Sciences | 2025-04-01 |
| REXULTI General Use Results Survey in Patients With Hyperactivity, or Aggressive Behavior Associated With Alzheimer's Dementia | Brexpiprazole | — | Recruiting | Otsuka Pharmaceutical Co., Ltd. | 2025-03-14 |
| Domperidone on the Composition of Preterm Breastmilk Using a Human Milk Mid-infrared Spectroscopy Analyzer | Domperidone | — | Enrolling by invitation | Centro Hospitalar de Lisboa Central | 2025-02-17 |
| Effects of Lurasidone on Left Ventricle Systolic Functions | Lurasidone | — | Not yet recruiting | Aydin Adnan Menderes University | 2024-11-19 |
| Efficacy of Domperidone (a Prokinetic Agent) on Time in Range in Digestively Asymptomatic Type I Diabetic Patients With Delayed Gastric Emptying (Gastro-TIR) | Domperidone | Phase 3 | Not yet recruiting | University Hospital, Rouen | 2024-11-19 |
| The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia. | Brexpiprazole | Phase 1 | Recruiting | Sichuan Kelun Pharmaceutical Co.,Ltd. | 2024-11-05 |
| Voice-Based Biomarkers: A Novel Approach to Monitoring and Predicting Schizophrenia Relapses | Paliperidone | Not applicable | Recruiting | Centre Hospitalier St Anne | 2024-09-25 |
| Precision Care for Major Depressive Disorder | Brexpiprazole | Phase 4 | Enrolling by invitation | University of California, San Francisco | 2024-08-30 |
| Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms. | Ziprasidone | Phase 3 | Recruiting | Louisiana State University Health Sciences Center Shreveport | 2024-07-01 |
| Sequential Multiple Assignment Randomized Trial for Bipolar Depression | Cariprazine, Lurasidone | Phase 4 | Active, not recruiting | Massachusetts General Hospital | 2024-05-30 |
| Maternal And Infant Antipsychotic Study | Lurasidone, Ziprasidone | — | Recruiting | Icahn School of Medicine at Mount Sinai | 2023-09-22 |
| Real-life Assessment of Brexpiprazole (Rexulti) in Schizophrenia and in Depressive Disorders | Brexpiprazole | — | Recruiting | Dr. Albert Kar-Kin Chung | 2023-07-27 |
| Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy | Prochlorperazine | Phase 3 | Recruiting | Proton Collaborative Group | 2023-05-12 |
| Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas | Prochlorperazine | Phase 1 / Phase 2 | Recruiting | SignPath Pharma, Inc. | 2023-03-15 |
| REALITY MONITORING AND DOPAMINE | Domperidone, Sulpiride | Not applicable | Recruiting | Hôpital le Vinatier | 2023-02-02 |
| Safety and Tolerability of Open-Labeled Iloperidone in Adolescents | Iloperidone | Phase 4 | Recruiting | Vanda Pharmaceuticals | 2022-12-13 |
| Chinese Longitudinal and Systematic Study of Bioplar Disorder | Lurasidone | Not applicable | Recruiting | First Affiliated Hospital of Zhejiang University | 2022-07-29 |
| Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia | Brexpiprazole | Phase 3 | Recruiting | Otsuka Pharmaceutical Co., Ltd. | 2022-04-13 |
| 5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC | Prochlorperazine | Phase 2 | Recruiting | Barbara Burtness | 2022-04-07 |
| Apomorphine in Severe Brain-injured Patients | Domperidone | Phase 2 / Phase 3 | Recruiting | University of Liege | 2022-01-28 |
| Compassionate Use of Domperidone for Refractory Gastroparesis | Domperidone | Not applicable | Recruiting | Jose Cocjin | 2021-01-07 |
| "Extended" (Alternate Day) Antipsychotic Dosing | Paliperidone, Paliperidone palmitate | Phase 4 | Recruiting | Centre for Addiction and Mental Health | 2020-07-21 |
| HEALEY ALS Platform Trial - Master Protocol | Pridopidine | Phase 2 / Phase 3 | Active, not recruiting | Merit E. Cudkowicz, MD | 2020-03-05 |
| Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis | Itopride | Phase 3 | Recruiting | Tanta University | 2019-11-13 |
| Tick-borne Encephalitis and Borrelial Antibodies in Serum | Thiethylperazine | Not applicable | Recruiting | University Medical Centre Ljubljana | 2019-05-20 |
| Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia | Ziprasidone | Phase 1 | Active, not recruiting | University of Arizona | 2018-12-19 |
| Bariatric Surgery and Pharmacokinetics of Chlorprothixene | Chlorprothixene | — | Recruiting | Norwegian University of Science and Technology | 2018-02-28 |
| Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema | Levosulpiride | Phase 2 | Recruiting | Carmen Clapp | 2017-05-22 |
| Evaluation of D3 Receptor Occupancy Using FLUORTRIOPRIDE ([18F]FTP) PET/CT | Perphenazine | Phase 1 / Phase 2 | Active, not recruiting | University of Pennsylvania | 2016-06-28 |
| Domperidone in Treating Patients With Gastrointestinal Disorders | Domperidone | Phase 3 | Active, not recruiting | M.D. Anderson Cancer Center | 2012-10-01 |
| National Pregnancy Registry for Psychiatric Medications | Aripiprazole lauroxil | — | Recruiting | Massachusetts General Hospital | 2010-11-23 |